CVE-2022-31057

Authenticated Stored XSS in Shopware Administration

Description

Shopware is an open source e-commerce software made in Germany. Versions of Shopware 5 prior to version 5.7.12 are subject to an authenticated Stored XSS in Administration. Users are advised to upgrade. There are no known workarounds for this issue.

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.20%
Vendor Advisory shopware.com
Affected: shopware shopware
Published at:
Updated at:

References

Link Tags
https://github.com/shopware/shopware/security/advisories/GHSA-q754-vwc4-p6qj third party advisory
https://github.com/shopware/shopware/commit/3e025a0a3e123f4108082645b1ced6fb548f7b6f third party advisory patch
https://docs.shopware.com/en/shopware-5-en/security-updates/security-update-06-2022 release notes vendor advisory
https://packagist.org/packages/shopware/shopware product third party advisory

Frequently Asked Questions

What is the severity of CVE-2022-31057?
CVE-2022-31057 has been scored as a medium severity vulnerability.
How to fix CVE-2022-31057?
To fix CVE-2022-31057, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-31057 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-31057 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-31057?
CVE-2022-31057 affects shopware shopware.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.